Chronic rhinosinusitis (CRS) is an inflammatory disease of the paranasal sinuses which causes symptoms of nasal obstruction, thick nasal drainage, smell dysfunction, and facial pain or pressure for a time period of greater than 12 weeks [1]. The management of CRS begins with medical therapy which can include a combination of large volume saline irrigations, intranasal corticosteroids, oral corticosteroids, and/or antibiotics depending on the phenotype/endotype of the CRS, typically for a 3–4 week period [1]. The response rate to medical therapy alone is quite varied and has been reported to be 37.5–90% [2, 3]. When patients fail to respond to appropriate medical therapy, which can be defined as persistence of symptoms with findings of sinonasal inflammation on radiography or endoscopy, they can be offered sinus surgery.